BiotechTube
Corcym

Corcym

London, United Kingdom· Est.
corcym.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Corcym is a UK-based, private medical device company founded in 2020, dedicated to the structural heart market. It has assembled a portfolio of established and innovative surgical technologies, such as the Perceval sutureless valve, with a heritage spanning over 50 years through its acquired products. The company operates globally, targeting cardiac surgeons with a customer-centric model focused on professional education and clinical evidence. Its strategy is to become a leading partner to heart surgeons by providing a complete suite of surgical solutions.

Cardiovascular

Technology Platform

Portfolio of surgical heart valve technologies including sutureless aortic valve replacement (Perceval), mechanical valves (Carbomedics, Bicarbons), bioprosthetic tissue valves, and geometric annuloplasty repair devices (HAART).

Funding History

1
Series AUndisclosed

Opportunities

The aging global population is increasing the prevalence of valvular heart disease, creating a growing patient pool.
The surgical trend towards minimally invasive and rapid deployment techniques favors adoption of sutureless valves like Perceval.
Expansion into large markets like China, where Perceval recently gained approval, represents a significant growth avenue.

Risk Factors

Corcym faces intense competition from larger, well-established medtech giants with greater resources.
The long-term growth of transcatheter valve replacement procedures could pressure the traditional surgical valve market.
The company's growth is heavily reliant on the successful commercialization and surgeon adoption of its key innovative product, the Perceval valve.

Competitive Landscape

Corcym competes in the global surgical structural heart market against dominant players like Edwards Lifesciences, Abbott, Medtronic, and Boston Scientific. Its strategy is to differentiate through a focused, surgeon-centric partnership model and a specific portfolio mix of legacy and innovative technologies, particularly the Perceval sutureless valve.

More companies in United Kingdom →